Curative Biosciences (Curative Biosciences) Change In Payables And Accrued Expense : $-0.01 Mil (TTM As of Mar. 2018)

View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences Change In Payables And Accrued Expense?

Curative Biosciences's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2018 was $0.00 Mil. It means Curative Biosciences's Accounts Payable & Accrued Expense stayed the same from Dec. 2017 to Mar. 2018 .

Curative Biosciences's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2017 was $0.00 Mil. It means Curative Biosciences's Accounts Payable & Accrued Expense stayed the same from Jun. 2016 to Jun. 2017 .

Curative Biosciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Curative Biosciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences Change In Payables And Accrued Expense Chart

Curative Biosciences Annual Data

Trend

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.04

0.24

0.19

0.05

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-0.01	-

Curative Biosciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

Curative Biosciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biosciences (Curative Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131

Website

http://www.CurativeBio.com

Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines